Moderator Greg Bensch and a panel of allergists discuss itch control, access barriers, and guideline gaps shaping newer AD topicals in this clinical forum.
Back
Evolving Approaches to Topical Treatment in Atopic Dermatitis
Highlights from a series of clinical forums spotlighting discussions on topical therapies and other novel treatments for atopic dermatitis in 2026.
Evolving Approaches to Topical Treatment in Atopic Dermatitis
Episodes
All
All
NYC allergists discuss tapinarof's 80-day treatment-free interval, ruxolitinib's box warning hurdles, and more.
Dallas allergist-immunologists discuss real-world use of non-steroidal topicals in AD, steroid phobia, and the nematode story.
Advertisement
Advertisement
Trending on HCPLive
1
Evolocumab Prevents Recurrent Cardiovascular Events Following MI or Stroke
2
ESC 2026 Recap: 5 Practice-Changing Trials to Know
3
FAQ: Treating Fall Allergic Rhinitis Under The 2026 ARIA-EAACI Update
4
The HCPFive: Top News for Healthcare Providers from the Week of 09/06
5